Search - tctmd.com

Displaying 221 - 240 of 259

Sort: Relevancy | Date

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

PCI前肾功能评估的方法选择很重要

L.A. McKeown

June 29, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante

L.A. McKeown

June 29, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Conference News ACC 2015

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

Todd Neale

March 15, 2015

News Daily News

对慢性肾病患者，CABG比PCI的长期效果好

Yael L. Maxwell

January 28, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

Yael L. Maxwell

January 28, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCI

Yael L. Maxwell

January 28, 2015

News Daily News

Dabigatran Carries Higher Risk of Major Bleeds, Lower Risk of Intracranial Hemorrhage

Todd Neale

November 06, 2014

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Carlo Briguori

September 16, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Daily News

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

May 07, 2014

News Daily News

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Yael L. Maxwell

April 17, 2014

Advertisement

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

PCI前肾功能评估的方法选择很重要

Method Chosen to Estimate Pre-PCI Kidney Function Matters

El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

对慢性肾病患者，CABG比PCI的长期效果好

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

For CKD Patients, CABG Favored Long-term Over PCI

Dabigatran Carries Higher Risk of Major Bleeds, Lower Risk of Intracranial Hemorrhage

Acute Hyperglycemia Worsens Post-AMI Prognosis

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Clinical Trial Updates: RenalGuard, AVERT, etc.

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content